Health ❯Healthcare ❯Pharmacology ❯GLP-1 Receptor Agonists

Semaglutide and Tirzepatide

Bariatric Surgery Surpasses GLP-1 Drugs in Real-World Weight Loss

New findings show surgery delivers more durable weight loss with lower psychiatric risks compared to weekly semaglutide or tirzepatide injections.

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

Tirzepatide Outperforms Semaglutide in Weight-Loss Trial